<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">Oncohematology</journal-id><journal-title-group><journal-title xml:lang="en">Oncohematology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкогематология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1818-8346</issn><issn publication-format="electronic">2413-4023</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82</article-id><article-id pub-id-type="doi">10.17650/1818-8346-2011-6-4-39-49</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>LECTURES AND LITERATURES REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЛЕКЦИИ ДЛЯ ВРАЧЕЙ И ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Lymphoid hematological malignancies</article-title><trans-title-group xml:lang="ru"><trans-title>Гемобластозы лимфоидного происхождения</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Domninskiy</surname><given-names>D. A.</given-names></name><name xml:lang="ru"><surname>Домнинский</surname><given-names>Д. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>D7777777@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Federal Research Center of Pediatric Hematology, Oncology and Immunology</institution></aff><aff><institution xml:lang="ru">ФГБУ ФНКЦ ДГОИ им. Дмитрия Рогачева Минздравсоцразвития России</institution></aff></aff-alternatives><content-language>ru</content-language><pub-date date-type="pub" publication-format="electronic" iso-8601-date="2011-11-23"><day>23</day><month>11</month><year>2011</year></pub-date><pub-date date-type="collection"><year>2011</year></pub-date><volume>6</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>39</fpage><lpage>49</lpage><history><date date-type="received" iso-8601-date="2014-07-23"><day>23</day><month>07</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-07-23"><day>23</day><month>07</month><year>2014</year></date></history><pub-history><event event-type="received"><event-desc>Received:<date date-type="received" iso-8601-date="2014-07-23"><day>23</day><month>07</month><year>2014</year></date></event-desc></event><event event-type="accepted"><event-desc>Accepted:<date date-type="accepted" iso-8601-date="2014-07-23"><day>23</day><month>07</month><year>2014</year></date></event-desc></event><event event-type="pub"><event-desc>Published:<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2011-11-23"><day>23</day><month>11</month><year>2011</year></pub-date></event-desc></event></pub-history><permissions><copyright-year>2011</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncohematology.abvpress.ru/ongm/article/view/82">https://oncohematology.abvpress.ru/ongm/article/view/82</self-uri><abstract xml:lang="en"><p>.</p></abstract><trans-abstract xml:lang="ru"><p>.</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Домнинский Д.А. Молекулярные механизмы лейкозогенеза. Лекция № 1. Онкогематол 2010;4:49–56.</mixed-citation><mixed-citation xml:lang="ru">Домнинский Д.А. Молекулярные механизмы лейкозогенеза. Лекция № 1. Онкогематол 2010;4:49–56.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Домнинский Д.А. Молекулярные механизмы лейкозогенеза. Лекция № 2. Механизмы реализации сигнальной трансдукции. Онкогематол 2011;1:76–84.</mixed-citation><mixed-citation xml:lang="ru">Домнинский Д.А. Молекулярные механизмы лейкозогенеза. Лекция № 2. Механизмы реализации сигнальной трансдукции. Онкогематол 2011;1:76–84.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Домнинский Д.А. Молекулярные механизмы лейкозогенеза. Лекция № 3. Гемобластозы миелоидного происхождения. Онкогематол 2011;3:82–93.</mixed-citation><mixed-citation xml:lang="ru">Домнинский Д.А. Молекулярные механизмы лейкозогенеза. Лекция № 3. Гемобластозы миелоидного происхождения. Онкогематол 2011;3:82–93.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Campo E., Swerdlow S., Harris N. et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011;117: 5019–32.</mixed-citation><mixed-citation xml:lang="ru">Campo E., Swerdlow S., Harris N. et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011;117: 5019–32.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Jaffe E., Harris N., Stein H., Isaacson P. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 2008;112:4384–99.</mixed-citation><mixed-citation xml:lang="ru">Jaffe E., Harris N., Stein H., Isaacson P. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 2008;112:4384–99.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Asnafi V., Macintyre E. Molecular pathogenesis of acute lymphoblastic leukaemia: an immunoglobulin/T cell receptor-centric view. Hematol Education (13 Congress EHA) 2008;2:54–63.</mixed-citation><mixed-citation xml:lang="ru">Asnafi V., Macintyre E. Molecular pathogenesis of acute lymphoblastic leukaemia: an immunoglobulin/T cell receptor-centric view. Hematol Education (13 Congress EHA) 2008;2:54–63.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Chiaretti S., Foa R. T-cell acute lymphoblastic leukemia. Haematol 2009;94:160–2.</mixed-citation><mixed-citation xml:lang="ru">Chiaretti S., Foa R. T-cell acute lymphoblastic leukemia. Haematol 2009;94:160–2.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Bende R., Smit L., van Noesel C. Molecular pathways in follicular lymphoma. Leukemia 2007;21:18–29.</mixed-citation><mixed-citation xml:lang="ru">Bende R., Smit L., van Noesel C. Molecular pathways in follicular lymphoma. Leukemia 2007;21:18–29.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Gollin С. Mechanisms leading to nonrandom, nonhomologous chromosomal translocations in leukemia. Semin Cancer Biol 2007;17:74–9.</mixed-citation><mixed-citation xml:lang="ru">Gollin С. Mechanisms leading to nonrandom, nonhomologous chromosomal translocations in leukemia. Semin Cancer Biol 2007;17:74–9.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. De Mendibil I., Vizmanos J., Novo F. Signatures of selection in fusion transcripts resulting from chromosomal translocations in human cancer. PLoS ONE 2009;4:e4805.</mixed-citation><mixed-citation xml:lang="ru">De Mendibil I., Vizmanos J., Novo F. Signatures of selection in fusion transcripts resulting from chromosomal translocations in human cancer. PLoS ONE 2009;4:e4805.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Jung D., Giallourakis C., Mostoslavsky R., Alt F. Mechanism and control of V(D) J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 2006;24:541–70.</mixed-citation><mixed-citation xml:lang="ru">Jung D., Giallourakis C., Mostoslavsky R., Alt F. Mechanism and control of V(D) J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 2006;24:541–70.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Nussenzweig A., Nussenzweig M. Origin of chromosomal translocations in lymphoid cancer. Cell 2010;141:27–38.</mixed-citation><mixed-citation xml:lang="ru">Nussenzweig A., Nussenzweig M. Origin of chromosomal translocations in lymphoid cancer. Cell 2010;141:27–38.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Gostissa M., Alt F., Chiarle R. Mechanisms that promote and suppress chromosomal translocations in lymphocytes. Annu Rev Immunol 2011;29:319–50.</mixed-citation><mixed-citation xml:lang="ru">Gostissa M., Alt F., Chiarle R. Mechanisms that promote and suppress chromosomal translocations in lymphocytes. Annu Rev Immunol 2011;29:319–50.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Aifantis I., Raetz E., Buonamici S. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 2008;8:380–90.</mixed-citation><mixed-citation xml:lang="ru">Aifantis I., Raetz E., Buonamici S. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 2008;8:380–90.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Grabher C., von Boehmer H., Look L. Notch1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006;6:347–59.</mixed-citation><mixed-citation xml:lang="ru">Grabher C., von Boehmer H., Look L. Notch1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006;6:347–59.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Seto M. Genetic and epigenetic factors involved in B-cell lymphomagenesis. Cancer Sci 2004;95:704–10.</mixed-citation><mixed-citation xml:lang="ru">Seto M. Genetic and epigenetic factors involved in B-cell lymphomagenesis. Cancer Sci 2004;95:704–10.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Schlissel M. Regulating antigen-receptor gene assembly. Nat Rev Immunol 2003;3: 890–9.</mixed-citation><mixed-citation xml:lang="ru">Schlissel M. Regulating antigen-receptor gene assembly. Nat Rev Immunol 2003;3: 890–9.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Gostissa M., Yan C., Bianco J. Longrange oncogenic activation of IgH/c-MYC translocations by the IgH 3’ regulatory region. Nature 2009;462:803–7.</mixed-citation><mixed-citation xml:lang="ru">Gostissa M., Yan C., Bianco J. Longrange oncogenic activation of IgH/c-MYC translocations by the IgH 3’ regulatory region. Nature 2009;462:803–7.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Рулина А., Спирин П., Прасолов В. Активированные лейкозные онкогены AML1-ETO и c-KIT: роль в развитии острого миелоидного лейкоза и современные подходы к их ингибированию. Успехи биологической химии 2010;50:349–86.</mixed-citation><mixed-citation xml:lang="ru">Рулина А., Спирин П., Прасолов В. Активированные лейкозные онкогены AML1-ETO и c-KIT: роль в развитии острого миелоидного лейкоза и современные подходы к их ингибированию. Успехи биологической химии 2010;50:349–86.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Pui C-H., Relling M., Downing J. Acute l Acute lymphoblastic leukaemia. Lancet 2008;371:1030–43.</mixed-citation><mixed-citation xml:lang="ru">Pui C-H., Relling M., Downing J. Acute l Acute lymphoblastic leukaemia. Lancet 2008;371:1030–43.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">22. Teitell M., Pandolfi P. Molecular genetics of acute lymphoblastic leukemia. Annu Rev Pathol Mech Dis 2009;4:175–98.</mixed-citation><mixed-citation xml:lang="ru">Teitell M., Pandolfi P. Molecular genetics of acute lymphoblastic leukemia. Annu Rev Pathol Mech Dis 2009;4:175–98.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">23. Shaffer A., Rosenwald A., Staudt L. Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol 2002;2:920–33.</mixed-citation><mixed-citation xml:lang="ru">Shaffer A., Rosenwald A., Staudt L. Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol 2002;2:920–33.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">24. Cobaleda C., Schebesta A., Delogu A., Busslinger M. Pax5: the guardian of B cell identity and function. Nat Immunol 2007;8:463–70.</mixed-citation><mixed-citation xml:lang="ru">Cobaleda C., Schebesta A., Delogu A., Busslinger M. Pax5: the guardian of B cell identity and function. Nat Immunol 2007;8:463–70.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">25. Lenz G., Staudt L. Aggressive lymphomas. New Engl J Med 2010;362:1417–29.</mixed-citation><mixed-citation xml:lang="ru">Lenz G., Staudt L. Aggressive lymphomas. New Engl J Med 2010;362:1417–29.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">26. Klein U., Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008;8:22–33.</mixed-citation><mixed-citation xml:lang="ru">Klein U., Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008;8:22–33.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">27. Aukema S., Siebert R., Schuuring E. et al. Double-hit B-cell lymphomas. Blood 2011;117:2319–31.</mixed-citation><mixed-citation xml:lang="ru">Aukema S., Siebert R., Schuuring E. et al. Double-hit B-cell lymphomas. Blood 2011;117:2319–31.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">28. Schnell S., Van Vlierberghe P., Ferrando A. The molecular basis of T-cell acute lymphoblastic leukemia. Hematol Education (16 Congress EHA) 2011;5:1–8.</mixed-citation><mixed-citation xml:lang="ru">Schnell S., Van Vlierberghe P., Ferrando A. The molecular basis of T-cell acute lymphoblastic leukemia. Hematol Education (16 Congress EHA) 2011;5:1–8.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">29. Van Vlierberghe P., Pieters R., Beverloo B., Meijerink J. Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia. Brit J Haematol 2008;143:153–68.</mixed-citation><mixed-citation xml:lang="ru">Van Vlierberghe P., Pieters R., Beverloo B., Meijerink J. Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia. Brit J Haematol 2008;143:153–68.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">30. He H., Hua X., Yan J. Epigenetic regulations in hematopoietic Hox code. Oncogene 2011;30:379–88.</mixed-citation><mixed-citation xml:lang="ru">He H., Hua X., Yan J. Epigenetic regulations in hematopoietic Hox code. Oncogene 2011;30:379–88.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">31. Pui C-H. T-cell acute lymphoblastic leukemia: NOTCHing the way toward a better treatment outcome. Cancer Cell 2009;15:85–7.</mixed-citation><mixed-citation xml:lang="ru">Pui C-H. T-cell acute lymphoblastic leukemia: NOTCHing the way toward a better treatment outcome. Cancer Cell 2009;15:85–7.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">32. Koch U., Radtke F. Notch in T-ALL: new players in a complex disease. Trends in Immunol 2011;32:434–42.</mixed-citation><mixed-citation xml:lang="ru">Koch U., Radtke F. Notch in T-ALL: new players in a complex disease. Trends in Immunol 2011;32:434–42.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">33. Garbe A., von Boehmer H. TCR and Notch synergize in αβ versus γδ lineage choice. Trends in Immunol 2007;28:124–31.</mixed-citation><mixed-citation xml:lang="ru">Garbe A., von Boehmer H. TCR and Notch synergize in αβ versus γδ lineage choice. Trends in Immunol 2007;28:124–31.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">34. Lieber M. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem 2010;79:181–211.</mixed-citation><mixed-citation xml:lang="ru">Lieber M. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem 2010;79:181–211.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">35. McCord R., Dekker J. Translocation mapping exposes the risky lifestyle of B cells. Cell 2011;147:20–2.</mixed-citation><mixed-citation xml:lang="ru">McCord R., Dekker J. Translocation mapping exposes the risky lifestyle of B cells. Cell 2011;147:20–2.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">36. Schatz D., Ji Y. Recombination centres and the orchestration of V(D)J recombination. Nat Rev Immunol 2011;11:251–63.</mixed-citation><mixed-citation xml:lang="ru">Schatz D., Ji Y. Recombination centres and the orchestration of V(D)J recombination. Nat Rev Immunol 2011;11:251–63.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">37. Jhunjhunwala S., van Zelm M., Peak M., Murre C. Chromatin architecture and the generation of antigen receptor diversity. Cell 2009;138:435–8.</mixed-citation><mixed-citation xml:lang="ru">Jhunjhunwala S., van Zelm M., Peak M., Murre C. Chromatin architecture and the generation of antigen receptor diversity. Cell 2009;138:435–8.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">38. Osborne C., Chakalova L., Mitchell J. et al. Myc dynamically and preferentially relocates to a transcription factory occupied by IgH. PLoS Biol 2007;5:e192.</mixed-citation><mixed-citation xml:lang="ru">Osborne C., Chakalova L., Mitchell J. et al. Myc dynamically and preferentially relocates to a transcription factory occupied by IgH. PLoS Biol 2007;5:e192.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">39. Dyer M., Akasaka T., Capasso M. et al. Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers? Blood 2010;115:1490–9.</mixed-citation><mixed-citation xml:lang="ru">Dyer M., Akasaka T., Capasso M. et al. Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers? Blood 2010;115:1490–9.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">40. Kindt T., Goldsby R., Osborne B. Kuby Immunology (6 ed.). Freeman &amp; Company, 2006.</mixed-citation><mixed-citation xml:lang="ru">Kindt T., Goldsby R., Osborne B. Kuby Immunology (6 ed.). Freeman &amp; Company, 2006.</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">41. Speicher M., Carter N. The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genetics 2005;6:782–92.</mixed-citation><mixed-citation xml:lang="ru">Speicher M., Carter N. The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genetics 2005;6:782–92.</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">42. Guffei A., Sarkar R., Klewes L. et al. Dynamic chromosomal rearrangements in Hodgkin’s lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles. Haematol 2010;95:2038–46.</mixed-citation><mixed-citation xml:lang="ru">Guffei A., Sarkar R., Klewes L. et al. Dynamic chromosomal rearrangements in Hodgkin’s lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles. Haematol 2010;95:2038–46.</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">43. Lanctot C., Cheutin T., Cremer M. et al. Dynamic genome architecture in the nuclear space: regulation of gene expression in three dimensions. Nat Rev Genetics 2007;8:104–15.</mixed-citation><mixed-citation xml:lang="ru">Lanctot C., Cheutin T., Cremer M. et al. Dynamic genome architecture in the nuclear space: regulation of gene expression in three dimensions. Nat Rev Genetics 2007;8:104–15.</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">44. Parada L., McQueen P., Misteli T. Tissuespecific spatial organization of genomes. Genome Biology 2004;5:R44.1–R44.9.</mixed-citation><mixed-citation xml:lang="ru">Parada L., McQueen P., Misteli T. Tissuespecific spatial organization of genomes. Genome Biology 2004;5:R44.1–R44.9.</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">45. Разин С., Гаврилов А., Яровая О. Транскрипционные фабрики и пространственная организация эукариотического генома. Биохимия 2010;75:1477–88.</mixed-citation><mixed-citation xml:lang="ru">Разин С., Гаврилов А., Яровая О. Транскрипционные фабрики и пространственная организация эукариотического генома. Биохимия 2010;75:1477–88.</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">46. Chakalova L., Fraser P. Organization of transcription. Cold Spring Harb Perspect Biol 2010;2:1–15.</mixed-citation><mixed-citation xml:lang="ru">Chakalova L., Fraser P. Organization of transcription. Cold Spring Harb Perspect Biol 2010;2:1–15.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
